# Omnipod 5

Type: Product

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/omnipod-5
Canonical HTML page: https://getbiobrief.com/entity/omnipod-5

## Recent coverage (1 stories)

### ADMA Biologics Accused of Channel Stuffing: +20% Revenue Growth Was a ‘Mirage’
2026-07-12 01:30:43 · Sentiment: Negative · Impact: 7/10 · Sources: 4

Biotech firm ADMA Biologics faces securities fraud suit over alleged channel stuffing of ASCENIV, with Culper Research estimating real 2025 growth at -3% vs +20% reported.
Full story: https://getbiobrief.com/story/adma-biologics-channel-stuffing-securities-fraud

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.